J&J has maintained that the products don't cause cancer or contain asbestos. JOHNSON & JOHNSON PROPOSES TO PAY $6.5B TO SETTLE TALC OVARIAN CANCER LAWSUITS IN US "The overwhelming support for the ...

J&J has maintained that the products don’t cause cancer or contain asbestos. “The overwhelming support for the Plan demonstrates the company’s extensive, good-faith efforts to resolve this ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Johnson & Johnson announced updated results from the investigational Phase 1b RedirecTT-1 study evaluating the first-ever bispecific antibody combination of TALVEY, the first and only FDA-approved ...

After hours: September 27 at 7:57 PM EDT Loading Chart for JNJ ...